Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Sensus Healthcare, Inc.

Stage 4 · Declining · week 1

As of Oct 22, 2026, Sensus Healthcare is in Stage 4, the downtrend phase, now in its first week (since Oct 16, 2026). It closed at $2.87, 45.8% below its 52-week high and below its 200-day average, which is falling.

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. More about the company

$2.87
+0.35% today
$47.2M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is SRTS early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 16w
S2 37w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 4w → S4 16w → S1 5w → S2 10w → S3 4w → S2 37w → S3 4w → S4 13w → S1 10w → S4 12w → S1 9w → S2 10w → S3 9w → S4 12w → S1 7w → S4 1w current
Total tracked: 165 weeks across 16 stage runs.

SRTS among Medical Devices56th of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…56SRTSStage 4 · wk 146−5.3%
vs 52W High
-45.8%
$2.69 lo$5.30 hi
45.8% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 1
1w13w26w
Week 1, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-20.2%
200 DMA: $3.59 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.32x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-5.3%
3M
-5.3%
6M
-27.0%
YTD
-30.0%
1Y
-11.1%
Scan Membership
Breakout Watch
Latest: 2024-05-21
8 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 1 · Vol 0.32x
2026-10-21S4
Wk 1 · Vol 0.16x
2026-10-20S4
Wk 1 · Vol 1.58x
2026-10-19S4
Wk 1 · Vol 0.78x
2026-10-16S41→4
Wk 1 · Vol 0.40x
2026-10-15S1
Wk 8 · Vol 0.83x
2026-10-14S1
Wk 8 · Vol 0.33x
2026-10-13S1
Wk 7 · Vol 0.58x
2026-10-12S1
Wk 7 · Vol 0.24x
2026-10-09S1
Wk 7 · Vol 0.42x
2026-10-08S1
Wk 7 · Vol 0.60x
2026-10-07S1
Wk 7 · Vol 0.18x
Moving averages & range
50 DMA
$3.07
200 DMA
$3.59
52W High
$5.30
52W Low
$2.69
5D Low
$2.75
Resistance levels (recent highs)
20d High
$3.07
60d High
$3.54
120d High
$4.11
250d High
$5.30
Next resistance
+7.0%
to 20d High
ROE
-34.8%
Profit margin -88.4%
Dividend Yield
0.00%
P/B 1.3

Sensus Healthcare: quick answers

What stage is Sensus Healthcare in?

As of Oct 22, 2026, Sensus Healthcare (SRTS) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 16, 2026 and is in its first week there. What the four stages mean

Is Sensus Healthcare in an uptrend?

No. Sensus Healthcare is in a Stage 4 downtrend. It trades 20.2% below its 200-day average, which is falling.

How far is Sensus Healthcare from its 52-week high?

Sensus Healthcare closed at $2.87 on Oct 22, 2026, 45.8% below its 52-week high of $5.30. Its 52-week low is $2.69.

How has Sensus Healthcare performed over the past year?

As of Oct 22, 2026, Sensus Healthcare is down 11.1% over the past year and down 30.0% so far in 2026.

Which sector and industry is Sensus Healthcare in?

Sensus Healthcare is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.